Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
O-I Glass | OI | Aug 30, 2024 | 12.69 | -0.78 |
Oak Valley Bancorp | OVLY | Aug 30, 2024 | 26.67 | +0.08 |
Oak Woods Acquisition | OAKU | Aug 30, 2024 | 10.98 | 0.00 |
Oaktree Capital A Pref | OAK-A | Aug 30, 2024 | 23.14 | -0.56 |
Oaktree Capital Group B Pref | OAK-B | Aug 30, 2024 | 22.45 | -1.32 |
Oaktree Specialty | OCSL | Aug 30, 2024 | 17.13 | +0.71 |
Oatly ADR | OTLY | Aug 30, 2024 | 0.87 | -4.31 |
Oblong | OBLG | Aug 30, 2024 | 3.55 | -4.57 |
Occidental Petroleum | OXY | Aug 30, 2024 | 56.98 | -0.40 |
Ocean Biomedical | OCEA | Aug 30, 2024 | 1.13 | +4.31 |
Ocean Power Technologies | OPTT | Aug 30, 2024 | 0.18 | -0.71 |
Oceaneering International | OII | Aug 30, 2024 | 26.99 | -1.10 |
OceanFirst Financial | OCFC | Aug 30, 2024 | 17.87 | +0.79 |
OceanFirst Pref | OCFCP | Aug 30, 2024 | 25.12 | +0.64 |
OceanPal | OP | Aug 30, 2024 | 1.61 | +0.42 |
Ocugen | OCGN | Aug 30, 2024 | 1.30 | +2.36 |
Ocular Therapeutix | OCUL | Aug 30, 2024 | 8.82 | +3.04 |
Oculis | OCS | Aug 30, 2024 | 12.00 | -0.41 |
Ocuphire Pharma | OCUP | Aug 30, 2024 | 1.24 | -1.59 |
Oddity Tech | ODD | Aug 30, 2024 | 36.80 | +1.57 |
Odyssey Marine Exploration | OMEX | Aug 30, 2024 | 3.97 | -0.25 |
Offerpad Solutions A | OPAD | Aug 30, 2024 | 3.89 | -2.26 |
Office Properties | OPI | Aug 30, 2024 | 2.20 | -1.79 |
OFG Bancorp | OFG | Aug 30, 2024 | 45.99 | +1.57 |
OFS Capital | OFS | Aug 30, 2024 | 8.22 | +1.36 |
OFS Credit | OCCI | Aug 30, 2024 | 7.38 | +1.23 |
OFS Credit C Pref | OCCIO | Aug 30, 2024 | 24.42 | -0.01 |
OFS Credit E Pref | OCCIN | Aug 30, 2024 | 23.20 | -0.13 |
OGE Energy | OGE | Aug 30, 2024 | 39.56 | +0.51 |
Ohio Valley Bank | OVBC | Aug 30, 2024 | 24.50 | -1.17 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.